The role of glycosphinglipids in neurological disorders - Mechanisms of immune action

Annals of the New York Academy of Sciences

Volumn 845, Issue , 1998, Pages 285-306

  Yu, Robert K ^a   Ariga, Toshio ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EISAI CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENT; CYTOKINE; GLYCOLIPID; GLYCOSPHINGOLIPID; IMMUNOGLOBULIN M ANTIBODY; MYELIN ASSOCIATED GLYCOPROTEIN; AUTOANTIBODY; IMMUNOGLOBULIN M; OLIGOSACCHARIDE;

ANTIBODY SPECIFICITY; ANTIBODY TITER; CELLULAR IMMUNITY; CONFERENCE PAPER; DEMYELINATION; ELECTROPHYSIOLOGY; ENDONEURIUM; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; NERVE FIBER DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PARAPROTEINEMIA; PERIPHERAL NEUROPATHY; PROTEIN EXPRESSION; SCIATIC NERVE; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD; CARBOHYDRATE ANALYSIS; CHEMISTRY; DEMYELINATING DISEASE; IMMUNOLOGY; MOLECULAR GENETICS; RAT; REVIEW;

ANIMALIA;

ANIMALS; AUTOANTIBODIES; CARBOHYDRATE SEQUENCE; DEMYELINATING DISEASES; GLYCOSPHINGOLIPIDS; HUMANS; IMMUNOGLOBULIN M; MOLECULAR SEQUENCE DATA; NERVOUS SYSTEM DISEASES; OLIGOSACCHARIDES; PARAPROTEINEMIAS; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS;

EID: 0032546671     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09682.x     Document Type: Article

References (138)

1. IUPAC-IUB COMMISSION OF BIOCHEMICAL NOMENCLATURE. 1976. Lipids 12:455-463.
2. MARCUS, D. M. 1984. A review of the immunogenic and immunomodulatory role of glycosphingolipids. Mol. Immunol. 21:1083-1091.
3. RAPPORT, M. M. & Y. Y. HUANG. 1985. Present status of the immunology of gangliosides. Adv. Exp. Med. Biol. 174:1-25.
4. YU, R. K., H. YOSHINO & T. ARIGA. 1993. The role of glycosphingolipids in peripheral neuropathies and related disorders. In Glycobiology and the Brain, M. Nicolini and P. F. Zatta, Eds.: 155-177. Pergamon Press. Oxford.
5. WILLISON, H. J., J. VEITCH, G. PATERSON & P. G. KENNEDY. 1993. Miller Fischer syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiat. 56:204-206.
6. WILLISON H. J. & J. VEITCH. 1994. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fischer syndrome. J. Neuroimmunol. 50:159-165.
7. YUKI, N., S. SATO, S. TSUJI, T. OHSAWA & T. MIYATAKE. 1994. Frequent presence of anti-GQ1b antibody in Fischer's syndrome. Neurology 43:414-417.
8. CHIBA, A., S. KUSUNOKI, H. OBATA, R. MACHINAMI & I. KANAZAWA. 1993. Serum anti-GQ1b antibody is associated with opthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: Clinical and immunohistochemical studies. Neurology 43:1911-1917.
9. YUKI, N., S. SATO, S. TSUJI, I. HOZUMI & T. MIYATAKE. 1993. An immunologic abnormality common to Bickerstaffs brain stem encephalitis and Fisher's syndrome. J. Neurol. Sci. 118:83-87.
10. YUKI, N. 1996. Tryptophan-immobilized column absorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: A new approach to treatment. Neurology 46:1644-1651.
11. NEWSOME-DAVIS, J. 1997. Myasthenia gravis and the Miller-Fischer variant of Guillain-Barré syndrome. Curr. Opin. Neurol. 10:18-21.
12. CHIBA, A., S. KUSUNOKI, S. KUWATA, T. TSUJI, Y. SHIBATA & I. KANAZAWA. 1995. HLA and anti-GQ1b IgG antibody in Miller Fischer syndrome and Guillain-Barré syndrome. J. Neuroimmunol. 61:85-88.
13. YUKI, N., T. TAKI, M. TAKABASHI, K. SAITO, H. YOSHINO, T. TAI, S HANDA & T. MIYATAKE. 1994. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fischer's syndrome. Ann. Neurol. 36:791-793.
14. GALLARDO, E., C. SERRANO, C. PRAT & I. ILLA. 1996. Antiganglioside antibodies in neuropathies and motor neuropathies. Neurlogic 11:s75-s80.
15. JACOB, B. C., M. P. HAZENBERG, P. A. VAN DOORN, H. P. ENDTZ & F. G. VAN DER MECHE. 1997. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fischer syndrome. J. Infect. Dis. 175:729-733.
16. JACOB, B. C., J. MEULSTEE, P. A. VAN DOORN & F. G. MECHE. 1997. Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies to Guillain-Barré syndrome. Muscle Nerve. 20:446-452.
17. YUKI, N., M. TAKAHASHI, K. KASHIWASWE, K. TADOKORO & K. SAITO. 1997. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fischer's syndrome. Ann. Neurol. 42:28-33.
18. YUKI, N., N. YAMADA, S. SATO, E. OHAMA, Y. KAWASE, F. IKUTA & T. MIYATAKE. 1993. Association of IgG anti-GD1a antibody with severe Gullain-Barré syndrome. Muscle Nerve 16:642-647.
19. ILLA, I., N. ORTIZ, E. GALLARD, G. JUAREZ, J. M. GRAU & M. C. DALAKAS. 1995. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides. Ann. Neurol. 38:218-224.
20. VRIESENDORP, F. J., W. J. TRIGGS, R. F. MAYER & C. L. KOSKI. 1995. Electrophysiological studies in Guillain-Barré syndrome: Correlation with antibodies to GM1, GD1b and Campylobacter jejuni. J. Neurol. 242:460-465.
21. ENDERS, U., H. KARCH, K. V. TOYKA, M. MICHELS, J. SIELASEK, M. PETTE, J. HEESEMANN & H. P. HARTUNG. 1993. The spectrum of immune responses to Campylobactor jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann. Neurol. 34:136-144.
22. WILLISON, H. J. & P. G. KENNEDY. 1993. Gangliosides and bacterial toxin in Guillain-Barré syndrome. J. Neuroimmunol. 46:105-112.
23. WIRGUIN, L., L. SUTURKOVA-MILOSEVIC, P. DELLA-LATTA, T. FISHER, R. H. BROWN, JR. & N. LATOV. 1994. Monoclonal IgM antibodies to GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides. Ann. Neurol. 35:698-703.
24. ASPINALL, G. O., S. FUJIMOTO, A. G. MCDONALD, L. A. KURJANCZYK & J. L. PENNER. 1994. Lipopolysaccharides from Camplobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infec. Immun. 62:2122-2125.
25. KUSUNOKI, S., A. CHIBA, K. KON, S. ANDO, K. ARISAWA, A. TATE & I. KANAZAWA. 1994. N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann. Neurol. 35:570-576.
26. YUKI, N., T. TAKI & S. HANDA. 1996. Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Cainpylobactor jejuni enteritis. J. Neuroimmunol. 71:155-161.
27. VON WULFFEN, H., C. HARTARD & E. SCHAREIN. 1994. Seroactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome. J. Infect. Dis. 170:828-833.
28. VRIESENDROP, F. J., B. MISHU, M. J. BLASER & C. L. KOSKI. 1993. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: Correlation and prognosis. Ann. Neurol. 34:130-135.
29. YUKI, N., T. TAKI, M. TAKAHASHI, K. SAITO, T. TAI, T. MIYATAKE & S. HANDA. 1994. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect. Immun. 62:2101-2103.
30. YUKI, N., S. HANDA, T. TAI, M. TAKAHASHI, K. SAITO, Y. TSUJINO & T. TAKI. 1995. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J. Neurol. Sci. 130:112-116.
31. SALLOWAY, S., L. A. MERMEL, M. SEAMANS, G. O. ASPINALL, J. E. NAM SHIN, L. A. KURJANCZYK & J. L. PENNER. 1996. Miller-Fischer syndrome associated with Campylobacter jejuni lipopolysaccharide molecules that mimic human ganglioside GD3. Infect. Immun. 64:2945-2949.
32. HITOSHI, S., S. KUSUNOKI, K. KON, A. CHIBA, H. WAKI, A. ANDO & I. KANAZAWA. 1996. A novel ganglioside 9-O-acetyl GD1b, is recognized by serum antibodies in Guillain-Barré syndrome. J. Neuroimmunol. 66:95-101.
33. YUKI, N. & T. ARIGA. 1997. Antibodies to fucogangliosides in neurological diseases. J. Neurol. Sci. 150:81-84.
34. CARPO, M., E. NOBILE-OZAZIO, N. MEUCCI, M. GAMBA, S. BARBIERI, S. ALLERIA & G. SCARLATO. 1996. Anti-GD1a ganglioside antibodies in peripheral motor syndromes. Ann. Neurol. 39:539-543.
35. O'LEARY, C. P., J. VEITCH, W. F. DURWARD, A. M. THOMAS, A. M. REES & H. J. WILLISON. 1996. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J. Neurol. Neurosurg. Psychiat. 61:649-652.
36. YUKI, N., K. WAKABAYASHI, M. YAMADA & K. SEKI. 1997. Overlap of Guillain-Barré syndrome and Bickerstafls brainstem encephalitis. J. Neurolog. Sci. 145:119-121.
37. KUSUNOKI, S., A. CHIBA, T. TAI & I. KANAZAWA. 1993. Localization of GM1 and GD1b antigens in human peripheral nervous system. Muscle Nerve 16:752-756.
38. LARRIVIERE, M., A. LAGUENY, X. FERRER, E. ELLIE, P. SCHUERMANS & J. JULIEN. 1994. Multifocal motor neuropathy. Rev. Neurolog. 150:168-171.
39. PARRY, G. J. 1994. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve 17:97-99.
40. GARCIA GUICHO, C., A. GARCIA-MERINO & G. RABIO. 1995. Presence and isotype of antiganglioside antibodies in healthy persons, motor neuron disease, peripheral neuropathy, and other diseases of the nervous system. J. Neuroimmunol. 56:27-33.
41. SERRATRICE, G. 1993. Motor neuropathies and antiglycolipid antibodies. Clin. Exp. Neurol. 30:25-32.
42. HERRON, B., H. J. WILLISON, J. VEITCH, D. ROELKE, L. S. ILLIS & F. E. BOULTON. 1994. Monoclonal IgM cold agglutinins with anti-Prld specificity in a patient with peripheral neuropathy. Vox Sang. 67:58-63.
43. WILLISON, H. U., G. M. O'HANLON, G. PARTERSON, J. VEITCH, G. WILSON, M. ROBERTS, T. TANG & A. VINCENT. 1996. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V 1-18. J. Clin. Invest. 97:1155-1164.
44. FARRER, R. G., M. C. DALAKAS & R. H. QUARLES. 1996. Multiple antibodies to nerve glycoconjugates in a patient with neuropathy and monoclonal IgA gammopathy. J. Neuroimmunol. 66:71-76.
45. BRINDEL, I., J. L. PREUD'HOMME, J. M. VALLAT, D. VINCENT, J. L. VASQUEZ & M. O. JAUBERTEAU. 1994. Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy. Neurosci. Lett. 181:103-106.
46. MELENDEZ-VASQUEZ, C., J. REDFORD, P. P. CHOUDHARY, L. A. BRAY, P. MAITLAND, N. A. GREGSON, K. L. SMITH & R. A. HUGHES. 1997. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J. Neuroimmunol. 73:124-134.
47. UMEHARA, F., Y. KORE-EDA, T. ARIME, R. KUBOTA, K. ARIMURA & M. OSAME. 1997. Chronic sensory ataxic neuropathy and ophthalmoplegia with oculomotor nerve hypertrophy associated with IgM antibodies against gangliosides containing disialosyl groups. J. Neurol. Neurosurg. Psychiat. 62:673-674.
48. TAGAWA, Y., F. IRIE, Y. HIRABAYASHI & N. YUKI. 1997. Cholinergic neuron-specific ganglioside GQ1b alpha: A possible target molecule for serum IgM antibodies in some patients with sensory ataxia. J. Neuroimmunol. 75:196-199.
49. KREMER, D. M., R. H. LOPEZ, R. K. MIZUTANARI, L. J. KREMER, E. A. BACILE & G. A. NORES. 1997. Factor defining target specificity in antibody-mediated neuropathy: Density-dependent binding of anti-GD1a polyclonal IgG from a neurological patient. J. Neurosci. Res. 47:636-641.
50. LUGARESI, A., M. RAGNO, F. TORRIERI, G. DI GUGLIELMO, P. FERMANI & A. UNCINI. 1997. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis. J. Neurolog. Sci. 147:193-200.
51. HO, T. W., B. MISHU, C. Y. LI, D. R. CORNBLATH, J. W. L. GRIFFIN, A. K. ASBURY, M. J. BLASER & G. M. MCKHANN. 1995. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 110:597-605.
52. LEKMANN, A., O. SKJELDAL, E. SPONHEIM & L. SVENNERHOLM. 1995. Gangliosides in children with autism. Acta Pediatrics. 84:787-790.
53. SORICE, M., T. GRIGGI, G. NICODEMO, M. CIARDI, C. M. MASTROIANNI, L. LENTI & F. SORVICE. 1995. Cerebrospinal fluid antiganglioside antibodies in patients with AIDS. Infection 23:288-291.
54. LAKE, G. M., A. SISMANIS, T. ARIGA, M. YAMAWAKI, Y. GAO & R. K. YU. 1997. Antibodies to glycosphingolipid antigens in patients with immune-induced cochleovestibular disorders. Am. J. Otolog. 18:175-178.
55. YAMAWAKI, M., T. ARIGA, Y. GAO, J. S. YU, A. SISMANIS, & R. K. YU. 1998. Sulfoglucuronosyl glycolipids as putative antigens for autoimmune inner ear disease. J. Neuroimmunol. In press.
56. SHERMAN, W., M. R. OLERTE, C. MCKIERNAN, K. SWEENEY, N. LATOV, & A. P. HAYES. 1984. Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia. J. Neurol. Neurosurg. Psychiatr. 47:813-819.
57. ERNERUDH, L., E. BRODTKORB, T. OLSSON, C. A. VEDELER, H., NYLAND & G. BERLIN. 1986. Peripheral neuropathy and monoclonal IgM, with antibody activity against peripheral nerve myelin: Effect of plasma change. J. Neuroimmunol. 11:171-178.
58. HAAS, D. C. & A. H. TATUM. 1988. Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia. Ann. Neurol. 23:394-396.
59. DALAKAS, M. C., M. A. FLAUM, M. RICK, K. ENGEL & H. R. GRALNICK. 1983. Treatment of polyneuropathy in Waldenstrom's macroglobulinemia: Role of paraproteinemia immunologic studies. Neurology 33:1406-1410.
60. NOBILE-ORAZIO, E., L. BALDINI, S. BARBIERI, P. MARMIROLI, G. SPANGLO, E. FRANCOMANO & G. SCARLATO. 1988. Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann. Neurol. 24:93-97.
61. SMITH, T., W. SHERMAN, M. R. OLARTE & R. E. LOVELACE. 1987. Peripheral neuropathy associated with plasma cell dyscrasia; A clinical and electrophysiological follow-up study. Ann. Neurol. Scand. 75:244-248.
62. KELLY, J. J., L. S. ADELMAN, E. BERKMAN & I. BHAN. 1988. Polyneuropathies associated with IgM monoclonal gammopathies. Arch. Neurol. 45:1355-1359.
63. LATOV, N., A. P. HAYS, P. D. DONOFRIO, J. LIAO, H. ITO, S. MCGINNIS, K. MANOUSSOS, L. FREDDO, M. E. SHY, W. H. SHERMAN, H. W. CHANG, H. G. GREENBERG, J. W. ALBERS, A. G. ALESSI, D. KEREN, R. K. YU, L. P. ROWLAND & E. A. KABAT. 1988. Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease. Neurology 38:763-768.
64. SHY, M. E., T. HEIMAN-PATTERSON, G. J. PARRY, A. TAHMOUSH, V. A. EVAN & P. K. SCHICK. 1990. Lower motor neuron disease in a patient with autoantibodies against Gal(β1-3)GalNAc in gangliosides GM1 and GD1b: Improvement following immunotherapy. Neurology 40:842-844.
65. PESTRONK, A., D. R. CORNBLATH, A. A. ILYAS, H. BABA, R. H. QUARLES, J. W. GRIFFIN, K. ANDERSON & R. N. ADAMS. 1988. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann. Neurol. 24:73-78.
66. FELDMAN, E. L., M. B. BROMBERG, J. W. ALBERS & A. PESTRONK. 1991. Immunosuppressive treatment in multifocal motor neuropathy. Ann. Neurol. 30:397-401.
67. JELLOUN-DELLAGI, S. B., K. DELLAGI, D. BURGER, A. B. YOUNESS-CHENNOUFI, F. F. HENTATI, A. STECK & M. B. HAMIDA. 1992. Childhood peripheral neuropathy with autoantibodies to myelin glycoprotein P0. Ann. Neurol. 32:700-702.
68. KAHN, S. N., G. P. RICHES & J. KOHN. 1980. Paraproteinemia in neurological disease: Incidence association and classification of monoclonal immunoglobulins. J. Clin. Pathol. 30:617-621.
69. SMITH, I. S., S. N. KAHN, B. W. LACEY, R. H. M. KING, R. A. EAMES, D. J. WHYBREW & P. K. THOMAS. 1983. Chronic demyleinating neuropathy associated with benign IgM paraproteinemia. Brain 106:169-195.
70. LATOV, N., A. P. HAYES & W. H. SHERMAN. 1988. Peripheral neuropathy anti-MAG antibodies. CRC Crit. Rev. Neurobiol. 3:301-332.
71. FUKUSAKO, H., T. SAITO, M. TARA, M. OSAME & A. IGATA. 1986. Polyneuropathy with anti-myelin-associated glycoprotein antibody. A case report. Neurol. Med. (Tokyo) 24:66-69.
72. MEIER, C., K. ROBERTS, A. STECK, C. HESS, E. MILONUI & L. TSCHOPP. 1984. Polyneuropathy in Waldenstrom's macroglobulinemia: Reduction of endoneurial IgM deposits after treatment with chlorambucil and plasmapheresis. Acta Neuropathol. (Berlin) 64:297-307.
73. BARBIERI, S., E. NOBILE-ORAZIO, L. BALDINI, Z. FAYOUMI, E. MANFREDINI & M. SCHACHNER. 1987. Visual evoked potentials in patients with neuropathy and macroglobulinemia. Ann. Neurol. 22:663-666.
74. NOBILE-ORAZIO, E., P. MARMIROLI, L. BALDINI, G. SPAGNOL, S. BARBIERI, M. MOGGIO, N. POLI, E. POLLI & G. SCARLATO. 1987. Periperal neuropathy in macroglobulinemia: Incidence and antigen-specificity of M proteins. Neurology 37:1506-1514.
75. ARIGA, T., T. KOHRIYAMA, L. FREDDO, N. LATOV, M. SAITO, K. KON, S. ANDO, M. SUZUKI, M. E. HEMLING, K. L. RINEHART, S. KUSUNOKI & R. K. YU. 1987. Characterization of sulfated glucuronic acid containing glycolipids reacting IgM M-proteins in patients with neuropathy. J. Biol. Chem. 262:848-853.
76. CHOU, D. K. H., A. A. ILYAS, J. E. EVANS, C. COSTELLO, R. H. QUARLES & F. B. JUNGALWALA. 1986. Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. J. Biol. Chem. 261:11717-11725.
77. CHOU, D. K. H., G. A. SCHWARTING, J. E. EVANS & F. B. JUNGALWALA. 1987. Sulfoglucuronyl-neolacto series of glycolipids in peripheral nerve reacting with HNK-1 antibody. J. Neurochem. 49:865-873.
78. NAKANO, T., Y. ITO & T. OGAWA. 1993. Synthesis of sulfated glucuronyl glycosphingolipids; Carbohydrate epitopes of neural cell-adhesion molecules. Carbohydr. Res. 243:43-69.
79. ISOGAI, Y., T. KAWASE, H. ISHIDA, M. KISO & A. HASEGAWA. 1996. Synthetic studies on sialoglycocojugates. 90: Total synthesis of sulfated glucuronyl paraglobosides. Carbohydr. Chem. 15:1001-1023.
80. ISOGAI, H., M. ISHIDA, M. KISO & A. HASEGAWA. 1996. Synthetic studies on sialoglycoconjugates. 95: Total synthesis of sulfated glucuronyl lacosaminyl paraglobosides. J. Carbohydr. Chem. In press.
81. DAS, K., M. BASU, S. BASU, D. K. H. CHOU & F. B. JUNGALWALA. 1991. Biosynthesis in vitro of GlcA β1-3nLcOse4Cer by a novel glucuronyltransferase (GlcAT-1) from embryonic chicken brain. J. Biol. Chem. 266:5238-5243.
82. CHOU, D. K. H. & F. B. JUNGALWALA. 1993. Characterization and developmental expression of a novel sulfotransferase for the biosynthesis of sulfoglucuronyl glycolipids in the nervous system. J. Biol. Chem. 268:330-336.
83. CHOU, D. H. K. & F. B. JUNGALWALA. 1994. Characterization and developmental expression of lactotriosylceramide: Galactosyltransferase for the synthesis of neolactotetraosylceramide in the nervous system. J. Neurochem. 62:307-314.
84. OKA, S., K. TERAYAMA, C. KAWASHIMA & T. KAWASAKI. 1992. A novel glucuronyltransferase in nervous system presumably associated with the biosynthesis of HNK-1 carbohydrate epitope on glycoproteins. J. Biol. Chem. 267:22711-22714.
85. KOHRIYAMA, T., S. KUSUNOKI, T. ARIGA, J. E. YOSHINO, G. H. DEVRIES, N. LATOV & R. K. YU. 1987. Subcellular localization of sulfated glucuronic acid-containing glycolipids reacting with anti-myelin-associated glycoprotein antibody. J. Neurochem. 48:1516-1522.
86. YU, R. K., T. ARIGA, T. KOHRIYAMA, S. KUSUNOKI, Y. MAEDA & N. MIYATANI. 1990. Autoimmune mechanisms in peripheral neuropathies. Ann. Neurol. (Suppl.). 27:S30-S35.
87. ABO, T. & C. M. BALCH. 1981. A differentiation antigen of human NK and K cells identified by a monoclonal antibody HNK-1. J. Immunol. 127:1024-1029.
88. KRUSE, J., R. MAILHAMMER, H. WERNECKE, A. FAISSNER, L. SOMMER, C. GORIDIS & M. SCHACHNER. 1884. Neural cell adhesion molecules and myelin associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1. Nature (Lond.) 311:153-155.
89. JESSELL, T. M., M. A. HYNES & J. DODD. 1990. Carbohydrates and carbohydrate-binding proteins in the nervous system. Ann. Rev. Neurosci. 13:227-255.
90. JUNGALWALA, F. B. 1994. Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system - A review. Neurochem. Res. 19:945-967.
91. VOGEL, M., H. KOWALEWSKI, H. ZIMERMAN, A. JANETZKO, R. U. MARGOLIS & H. E. WOLLNY. 1991. Association of the HNK-1 epitope with 5′ nucleotidase from Torpedo marmorata (electric ray) electric organ. Biochem. J. 278:199-202.
92. MIKOL, D. D., J. R. GULCHER & K. STEFANSSON. 1990. The oligodendrocye-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J. Cell Biol. 110:471-479.
93. SNIPES, G. J., U. SUTER & E. M. SHOOTER. 1993. Human peripehral myelin protein-22 expression the L2/HNK-1 carbohydrate adhesion epitope. J. Neurochem. 61:1961-1964.
94. SUGAWALA, K., Y. TANAKA, S. YAMADA, N. SENO, H. KITAGAWA, S. M. HASLAM, H. R. MORRIS & A. DELL. 1996. Novel sulfated oligosaccharides containing 3-O-sulfated glucuronic acid from king crab cartilage chondroitin sulfate K. J. Biol. Chem. 271:26745-26754.
95. HALL, H., S. CARBONETTO & M. SCHACHNER. 1997. L1/HNK-1 carbohydrate and β1 integrin-dependent neural cell adhesion to laminin-1. J. Neurochem. 68:544-553.
96. TUCKER, G. C., H. AOYAMA, M. LIPINSKI, T. THOMAS & J. P. THIERY. 1984. Identical reactivity of monoclonal antibodies HNK-1 and NC-1: Conservation in vertebrates on cells derived from the neural primordium and some leukocytes. Cell Differ. 14:223-230.
97. MERKOURI, E. & R. MATSAS. 1992. Monoclonal antibody BM89 recognizes a novel surface glycoprotein of the L2/HNK-1 family in the developing mammalian nervous system. Neuroscience 50:53-68.
98. NAEGELE, J. R. & C. J. BARNSTABLE. 1991. A carbohydrate epitope defined by monoclonal antibody VC1.1 is found on N-CAM and other cell adhesion molecules. Brain Res. 559:118-129.
99. YAMAWAKI, M., T. ARIGA, J. W. BIGBEE, H. OZAWA, I. KAWASHIMA, T. TAI & R. K. YU. 1996. Generation and characterization of anti-sulfoglucuronosyl paragloboside monoclonal antibody NGR50 and its immunoreactivity with peripheral nerve. J. Neurosci. Res. 44:586-593.
100. TOKUDA, A., T. ARIGA, Y. ISOGAI, S. KOMBA, M. KISO, A. HASEGAWA, T. TAI & R. K. YU. 1998. On the specificy to anti-sulfoglucuronosyl glycolipid antibodies. J. Carbohydr. Chem. In press.
101. ARIGA, T., S. KUSUNOKI, K. ASANO, M. OSHIMA, M. ASANO, M. MANNEN & R. K. YU. 1990. Localization of sulfated glucuronyl glycolipids in human dorsal root and sympathetic ganglia. Brain Res. 519:57-64.
102. YU, R. K., H. YOSHINO, M. YAMAWAKI, J. E. YOSHINO & T. ARIGA. 1994. Subcellular distribution of sulfated gucuronyl glycolipids in human peripheral motor and sensory neurves. J. Biomed. Med. 1:167-171.
103. TOKUDA, A., T. ARIGA, M. YAMAWAKI, A. SISMANIS, G. M. LAKE & R. K. YU. 1996. Antibodies to sulfoglucuronosyl glycolipids (SGGLs) in autoimmune inner ear disease. J. Neurochem. Suppl. 66:S39A.
104. YOSHINO, H., Y. MAEDA, M. KING, M. J. CARTWRIGHT, D. W., RICHARDS, T. ARIGA & R. K. YU. 1993. Sulfated glucuronyl glycolipids and gangliosides in the optic nerve of human. Neurology 43:408-411.
105. SCHWARTING, A., F. B. JUNGALWALA, D. H. K. CHOU, A. M. BOYER & M. YAMAMOTO. 1987. Sulfated glucuronic acid-containing glycoconjugates are temporally and spatially regulated in the developing mammalian nervous system. Dev. Biol. 120:65-76.
106. CHOU, D. H. K., N. PRASAGARAO, O. KOUL & F. B. JUNGALWALA. 1991. Developmental expression of HNK-1 reactive antigens in rat cerebral cortex and molecular heterogeniy of sulfoglucuronyl neolactotetraosylceramide in CNS versus PNS. J. Neurochem. 57:852-858.
107. HOLLY, J. A. & R. K. YU. 1987. Localization of glycoconjugates recognized by the HNK-1 antibody in mouse and chick embryos during neural development. Dev. Neurosci. 9:105-229.
108. PRASADARO, N., O. KOUL, S. A. TOBET, D. H. K. CHOU & F. B. JUNGALWALA. 1990. Developmental expression of HNK-1 reactive antigens in the rat cerebellum and localization of sulfoglucuronyl glycolipids in molecular layer and deep cerebellar nuclei. J. Neurochem. 55:2024-2030.
109. MIYATANI, N., T. KOHRIYAMA, Y. MAEDA & R. K. YU. 1990. Sulfated glucurononyl paragloboside in rat brain microvessels. J. Neurochem. 55:577-582.
110. KANDA, T., H. YOSHINO, T. ARIGA, M. YAMAWAKI & R. K. YU. 1994. Glycolipid antigens in cultured bovine brain microvascular endothelial cells: Sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy. J. Cell. Biol. 126:235-246.
111. JUNGALWALA, F. B., D. K. H. CHOU, Y. SUZUKI & G. MAXWELL. 1992. Temporal expression of HNK-1 reactive sulfoglucuronyl glycolipids in cell culture quail trunk neural crest cells: Comparison with other developmentally regulated glycolipids. J. Neurochem. 58:1045-1051.
112. BREIDBACH, O., R. DENNIS, J. MARX, C. GORLACH, H. WEIGANDT & R. WEGERHOFF. 1992. Insect glial cells show differential expression of a glycolipid-derived, glucuronic acid-containing epitope throughout neurogenesis. Detection during post-embryogenesis and regeneration in the central nervous system of Tenebrio molitor 1. Neurosci. Lett. 147:5-8.
113. SUGITA, M., S. ITONORI, F. INAGAKI & T. HORI. 1989. Characterization of two glucuronic acid-containing glycosphingolipids in larvae of the green-bottle fly, Lucilia caesar. J. Biol. Chem. 264:15028-15033.
114. PRASADARAO, N., S. A. TOBEL & F. B. JUNGALWALA. 1990. Effect of different fixatives on immunocytochemical localization of HNK-1 reactive antigens in cerebellum. A method for differentiating the localization of the same carbohydrate epitope on proteins versus lipids. J. Histochem. Cytochem. 38:1193-1200.
115. MARTINI, R., E. BOLLESEN & M. SCHACHNER. 1988. Immunocytological localization of the major peripheral nervous system glycoprotein PO and the L2/HNK-1 and L3 carbohydrate structures in developing an adult mouse sciatic nerve. Dev. Biol. 129:330-338.
116. MOHAN, P. S., J. LAITINEN, J. MERENMICS, H. RAUVALA & F. B. JUNGALWALA. 1992. Sulfoglycolipids bind to adhesive protein amphoterin (P30) in the nervous system. Biochem. Biophycs. Res. Commun. 182:689-696.
117. NAIR, S. M. & F. B. JUNGALWALA. 1997. Characterization of a sulfoglucuronyl carbohydrate binding protein in the developing nervous system J. Neurochem. 68:1286-1297.
118. MERENMICS, J. & H. RAUVALA. 1990. Molecular cloning of 180 kDa growth associated protein of developing brain. J. Biol. Chem. 265:16721-16724.
119. NEEDLHAM, L. K. & R. L. SCHNAAR. 1993. The HNK-1 reactive sulfoglucuronyl glycolipids are ligands for L-selectin and P-selectin but not E-selectin. Proc. Natl. Acad. Sci. USA. 90:1359-1362.
120. NEMNI, R., G. GALASSI, N. LATOV, W. H. SHERMAN, M. R. OLARTE & A. P. HAYS. 1983. Polyneuropathy in nonmalignant IgM plasma cell dyscrasia: A morphological study. Ann. Neurol. 14:43-54.
121. REBAI, T., C. MHIRI & P. HEINE. 1989. Focal myelin thickenings in a peripheral neuropathy associated with IgM monoclonal gammopathy. Acta Neuropathol. 79:226-232.
122. HAYS, A. P., N. LATOV, M. TAKATSU & W. H. SHERMAN. 1987. Experimental demyelination of nerve induced by serum of paraproteins with neuropathy and an anti-MAG IgM M-protein. Neurology 37:242-256.
123. MONACO, S., B. BONETTI, S. FERRARI, G. MORETTO, E. NARDELLI, F. TEDESCO & T. E. MOLNES. 1990. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N. Engl. J. Med. 322:649-652.
124. KOHRIYAMA, T., T. ARIGA & R. K. YU. 1988. Preparation and characterization of antibodies against sulfated glucuronic acid-containing glycosphingolipids. J. Neurochem. 51:869-877.
125. YAMAWAKI, M., M. A. VASQYEZ, A. B. YOUNES, H. YOSHINO, T. KANDA, T. ARIGA, N. BAUMANN & R. K. YU. 1996. Sensitization of Lewis rats with sulfoglucuronosyl paragloboside: Electrophysiological and immunological studies of an animal model of peripheral neuropathy. J. Neurosci. Res. 44:58-65.
126. MAEDA, Y., C. F. BROSNAN, N. MIYATANI & R. K. YU. 1991. Preliminary studies on sensitization of Lewis rats with sulfated glucuronyl paraeloboside. Brain Res. 541:257-264.
127. MAEDA, Y., J. W. BIGBEE, R. MAEDA, N. MIYATANI, R. G. KALB & R. K. YU. 1991. Induction of demyelination by intraneural injection of antibodies against sulfoglucuronyl paragloboside. Exp. Neurol. 113:221-225.
128. KANDA, T., M. YAMAWAKI, T. ARIGA & R. K. YU. 1995. Interleukin l β up-regulates the expression of sulfoglucuronosyl paragloboside, a ligand for L-selection, in brain microvascular endothelial cells. Proc. Natl. Acad. Sci. USA 92:7897-7901.
129. ILYAS, A. A., R. H. QUARLES & T. D. MACINTOSH. 1984. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. Proc. Natl. Acad. Sci. USA 81:1225-1229.
130. OBI, T., S. KUSUNOKI, M. TAKATSU, K. MIZOGUCHI & Y. NISHIMURA. 1992. IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polysialogangliosides. Acta Neurol. Scand. 86:215-218.
131. WILLISON, H. J., G. M. O'HANLON, G. PETERSON, J. VEITCH, G. WILSON, M. ROBERTS, T. TANG & A. VINCENT. 1996. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V 1-18. J. Clin. Invest. 97:1155-1164.
132. YAMAWAKI, M., H. YOSHINO, T. KANDA, T. ARIGA & R. K. YU. 1993. Anti-sulfoglucuronyl glycolipid (SGGL) antibodies in Guillian-Barré syndrome. Ann. Neurol. 68:s46.
133. ILYAS, A. A., F. A. MITHEN, M. C. DALAKAS, M. WARGO, Z.-W. CHEN, L. BIELORY & S. D. COOK. 1991. Antibodies to sulfated glycolipids in Guillian-Barré syndrome. J. Neurol. Sci. 105:108-117.
134. YUKI, N., Y. TAGAWA & S. HANDA. 1996. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 70:1-6.
135. HO, T. W., B. MISHU, C. Y. LI, C. Y. GAO, D. R. CORNBLACCH, J. W. GRIFFIN, A. K. ASBURY, M. J. BLASNER & G. M. MCKHANN. 1995. Guillain-Barré syndrome in northern China: Relationship to Campylobacter jejuni infection and antiglycolipid antibodies. Brain 118:597-605.
136. BEN YOUNES-CHENNOUFI, A., A. ROIZER, M. DIB, P. BOUCHE, L. LACOMBLEZ, N. MOMBO, G. GEN SIMON, R. K. YU, N. BAUMANN & V. MEININGER. 1995. Anti-sulfoglucuronyl paragloboside IgM antibodies in amyotrophic lateral sclerosis. J. Neuroimmunol. 57:111-115.
137. IKEDA, J., T. KOHRIYAMA & S. NAKAMURA. 1997. Significance of antisulfoglucuronyl paragloboside antibody in sporadic motor neuron disease. Analysis with E-selectin. Neuroimmunology (Tokyo) 5:194-195.
138. YUKI, N. & T. MIYATAKE. 1998. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection. This issue.